TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 2 | -1 | -3 | 7 | 0 | 0 | 0 | 1 |
S | %wins | 100 | 100 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/24/18 18:36 | 10/22/18 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Brodie Steven G. | FL | O | VP - Pha | M.d | 46 | 3.45 | 0 | 13 | 41 | 46 | D | ||||||||||||||
7/6/17 21:25 | 7/5/17 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Brodie Steven G. | FL | O | VP of Op | M.d | 23 | 3.45 | 0 | 7 | 26 | 33 | D | ||||||||||||||
3/22/17 16:15 | 3/13/17 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Brodie Steven G. | FL | O | P,Pharma | S.dm | -397 | 7.93 | 3 | -50 | -76 | 16 | D | 54 | 21 | -6 | -20 | -5 | -6 | -4 | -3 | -1 | -1 | 13 | |||
3/17/17 19:31 | 3/13/17 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Brodie Steven G. | FL | O | P,Pharma | S.d | -132 | 8.00 | 3 | -17 | -25 | 49 | D | 66 | 18 | 0 | -14 | -2 | -2 | -2 | -1 | 0 | -4 | 1 | |||
12/7/16 17:12 | 12/6/16 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Brodie Steven G. | FL | O | P,Pharma | M.d | 17 | 1.69 | 3 | 10 | 18 | 66 | D | 120 | 20 | 1 | 15 | 26 | 1 | -2 | 1 | 0 | -1 | -5 | -14 | ||
3/14/16 17:15 | 3/10/16 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Brodie Steven G. | FL | O | Chief Sc | M.d | 74 | 1.48 | 2 | 50 | 840 | 56 | D | 110 | 48 | 6 | -7 | 3 | 14 | 2 | 0 | -4 | -9 | -3 | 21 | 18 | 14 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |